Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double Blind, Active Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for the Management of Breakthrough Pain in Opioid Tolerant Patients With Chronic Pain

NCT00813488 is registered in ClinicalTrials.gov with Cephalon as lead sponsor.

NCT NCT00813488
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00813488 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double Blind, Active Controlled Crossover Study to Evaluate the Efficacy and Safety of Fentanyl Buccal Tablets Versus Immediate Release Oxycodone for the Management of Breakthrough Pain in Opioid Tolerant Patients With Chronic Pain
Lead sponsor
Cephalon
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2008
Completion date
January 31, 2010
Enrollment
213 (actual)
Sites
50

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain